
Results
2
Stocks where the price continues to rise after more than a year of consistent gains.
2 companies
Lin BioScience
Market Cap: NT$50.4b
A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.
6696
NT$608.00
7D
26.0%
1Y
332.7%
ACRO Biomedical
Market Cap: NT$16.1b
Develops medical-grade regenerative biomaterials in Taiwan, Vietnam, and internationally.
6748
NT$226.00
7D
25.9%
1Y
447.9%